Stock Events

Sangamo Therapeutics (SGMO) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.37
-0.21
-0.04
0.12

Details

Expected EPS
-0.34
Actual EPS
-0.37
Surprise EPS
-0.03
Surprise Percent
+8.82%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.37 per share for Q2 2023.

0 Comments

Share your thoughts